Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial

June 2018

Author(s): Foster GR, Agarwal K, Cramp ME, Moreea S, Barclay S, Collier J, et al.

Details: Hepatology. 2018;67(6):2113-26

NIHR Acknowledged: Yes